Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
Empreendimentos Pague Menos's 1-Year ROIIC % for the quarter that ended in Jun. 2026 was 50.90%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Empreendimentos Pague Menos's 1-Year ROIIC % or its related term are showing as below:
BSP:PGMN3's 1-Year ROIIC % is ranked better than 81.77% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 3.54
vs BSP:PGMN3: 50.90
Empreendimentos Pague Menos (BSP:PGMN3) 1-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Empreendimentos Pague Menos 1-Year ROIIC % Related Terms
Empreendimentos Pague Menos 1-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Empreendimentos Pague Menos 1-Year ROIIC % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Empreendimentos Pague Menos's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Empreendimentos Pague Menos 1-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Empreendimentos Pague Menos's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Empreendimentos Pague Menos's 1-Year ROIIC % falls into.
1-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
1-Year Incremental Invested Capital
=
( 895.6287 (Jun. 2026) - 546.046 (Jun. 2025) )
/
( 7218.1 (Jun. 2026) - 6531.328 (Jun. 2025) )
=
349.5827
/
686.772
=
50.90%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Empreendimentos Pague Menos (BSP:PGMN3) has a 1-Year ROIIC % of 50.90 as of Jun. 2026. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Empreendimentos Pague Menos and its competitors. According to the industry distribution chart, Empreendimentos Pague Menos ranks #115 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 18.2%.
Is Empreendimentos Pague Menos' 1-Year ROIIC % too high?
Empreendimentos Pague Menos' current 1-Year ROIIC % is 50.90. The Healthcare Providers & Services industry median 1-Year ROIIC % is 3.54. Empreendimentos Pague Menos' value of 50.90 is 1337.9% above this industry median. Based on the distribution chart, Empreendimentos Pague Menos ranks #115 out of 631 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Empreendimentos Pague Menos has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Empreendimentos Pague Menos' 1-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Empreendimentos Pague Menos ranks #115 out of 631 companies for 1-Year ROIIC %. This places Empreendimentos Pague Menos in the top 18% of its industry — outperforming the majority of peers. The industry median 1-Year ROIIC % is 3.54. Empreendimentos Pague Menos' value of 50.90 is 1337.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Healthcare Providers & Services company?
The median 1-Year ROIIC % among Healthcare Providers & Services companies is 3.54, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a 1-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Empreendimentos Pague Menos's current 1-Year ROIIC % of 50.90 is 1337.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Empreendimentos Pague Menos and its competitors. For the Healthcare Providers & Services industry, the median 1-Year ROIIC % is 3.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Empreendimentos Pague Menos's current 1-Year ROIIC % is 50.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Empreendimentos Pague Menos stock overvalued right now?
Based on GuruFocus' analysis, Empreendimentos Pague Menos (BSP:PGMN3) is currently considered Fairly Valued. The stock's GF Value™ is R$3.57, compared to a current price of R$3.34 — trading 6.4% below its estimated fair value. The current 1-Year ROIIC % is 50.90 and 1337.9% above the Healthcare Providers & Services industry median of 3.54. Empreendimentos Pague Menos' overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For Empreendimentos Pague Menos (BSP:PGMN3), the current 1-Year ROIIC % is 50.90 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Empreendimentos Pague Menos (BSP:PGMN3) Overvalued in 2026?
Based on GuruFocus' analysis, Empreendimentos Pague Menos stock appears to be undervalued.
The current stock price of R$3.34 is trading 6.4% below its estimated GF Value™ of R$3.57.
GuruFocus considers Empreendimentos Pague Menos to be Fairly Valued.
Key valuation signals for BSP:PGMN3:
1-Year ROIIC %: 50.90
GF Value™: R$3.57 vs. price of R$3.34 (6.4% below fair value)
Industry Position: 1337.9% above the Healthcare Providers & Services median (#115 of 631)
No single metric tells the full story. See the BSP:PGMN3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Empreendimentos Pague Menos SA owns the Extrafarma brand and operates a pharmacy chain in Brazil. Through its physical and e-commerce stores, the company is engaged in the retail trade of medicines, perfumes, personal hygiene, and beauty products.
73GF Score
Get the complete analysis for BSP:PGMN3
1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PGMN3 has been successfully added to your 
